DexCom (DXCM) free cash flow

Free cash flow · fiscal 2025
$1.08B

DexCom (DXCM) generated free cash flow of $1.08B in fiscal 2025 (the year ended December 31, 2025). That is 70.8% higher than the $630.70M of fiscal 2024. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.08B
Change on fiscal 2024
+70.8%
Growth, 5 years
+31.2% a year
Growth, 10 years
+52.6% a year
Highest on record
$1.08Bfiscal 2025
Lowest on record
-$49.60Mfiscal 2010
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

DexCom free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 31.2% a year; over ten years the rate was 52.6% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.08B in fiscal 2025 and the lowest -$49.60M in fiscal 2010.

History · 17 fiscal years

Free cash flow by fiscal year

DexCom free cash flow, year by year

DexCom (DXCM) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.08B 70.8% up
2024$630.70M 23.2% up
2023$511.90M 68.0% up
2022$304.70M 471.7% up
2021$53.30M 80.7% down
2020$276.60M 105.7% up
2019$134.50M 139.8% up
2018$56.10M 115.8% up
2017$26.00M 5,100.0% up
2016$500.00K 96.8% down
2015$15.70M 112.2% up
2014$7.40M—
2013-$5.50M—
2012-$42.60M—
2011-$38.10M—
2010-$49.60M—
2009-$42.38M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of DexCom and comparable companies
CompanyFree cash flowFiscal year
Labcorp Holdings LH$1.21B2025
DexCom DXCM$1.08B2025
Koninklijke Philips PHG€504.00M2025
Roivant Sciences ROIV-$758.56M2026
West Pharmaceutical Services WST$468.90M2025
Quest Diagnostics DGX$1.36B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DXCM

DexCom, figure by figure

DexCom (DXCM) overview: price, valuation and scorecardAll health care companies by market value

DexCom free cash flow: questions and answers

What is DexCom's free cash flow?

DexCom (DXCM) generated free cash flow of $1.08B in fiscal 2025 (the year ended December 31, 2025). That is 70.8% higher than the $630.70M of fiscal 2024.

What is the growth rate of DexCom's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 31.2% a year; over ten years the rate was 52.6% a year.

What are the highest and lowest free cash flow figures on record for DexCom?

Across the 17 fiscal years on record (2009–2025), the highest was $1.08B in fiscal 2025 and the lowest -$49.60M in fiscal 2010.

How is DexCom's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For DexCom it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “DexCom (DXCM) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/DXCM/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.